SARS-CoV-2 evolution and vaccines: cause for concern?

Williams, Thomas C; Burgers, Wendy A

Williams, Thomas C; Burgers, Wendy A.

Williams TC; Medical Research Council Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK. Electronic address: Thomas.Christie.Williams@ed.ac.uk.
Burgers WA; Division of Medical Virology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.

Lancet Respir Med ; 9(4): 333-335, 2021 04.

Article in English | MEDLINE | ID: covidwho-1531927

Subject(s)

COVID-19 Vaccines/administration & dosage; COVID-19/prevention & control; Mutation Rate; SARS-CoV-2/genetics; Antibodies, Viral/immunology; COVID-19/epidemiology; COVID-19/virology; COVID-19 Vaccines/genetics; COVID-19 Vaccines/immunology; Humans; Immunogenicity, Vaccine; Pandemics/prevention & control; RNA, Viral/genetics; SARS-CoV-2/immunology; Sequence Analysis, RNA; Spike Glycoprotein, Coronavirus/genetics; Spike Glycoprotein, Coronavirus/immunology; Treatment Outcome; Vaccines, Synthetic/administration & dosage; Vaccines, Synthetic/genetics; Vaccines, Synthetic/immunology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Mutation Rate / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Lancet Respir Med Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google